Bicara Therapeutics

Bicara Therapeutics is owned by Biocon.

Biocon is one of the...

• Nifty 500.

Biocon is a company listed under the stock ticker BIOCON (IN).

Biocon has a direct presence in 2 countries.

Biocon has 3 subsidiaries including Bicara Therapeutics, Biocon Biologics and Syngene.

They are in:

• Biotechnology75%
• Pharmaceuticals25%

Acquisition, funding and merger involving Biocon.

• Bicara Therapeutics has just announced a $165 Million fundraising (posted on December 14 2023).
• Bicara Therapeutics has just announced a $100 Million fundraising (posted on March 8 2023).

View the org chart displaying its 20 main executives

Most searched biographies at Bicara Therapeutics

• Claire Mazumdar, Chief Executive Officer
• Vijay Kuchroo, Chairman of the Board
• Scott Robertson, Director

Popular executive movements at Bicara Therapeutics

• Jeltje Schulten has joined the company as Senior Vice President of Clinical and Medical Affairs  (posted on March 26 2024).
• Rita Dalal has joined the company as Vice President of Clinical Development  (posted on March 26 2024).
• Scott Robertson has joined the company as Director  (posted on October 16 2023).

Click here to view some more movements at Bicara Therapeutics

Popular executive movements at Biocon

• Peter Bains, who was Director, is promoted to Group Chief Executive Officer  (posted on September 19 2023).

Create your alert
to follow the executive moves at Bicara Therapeutics.

Biocon has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Bicara Therapeutics

Social media about Bicara Therapeutics

• Bicara Therapeutics on Wikipedia, Google News & Yahoo Finance
• Bicara Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Claire Mazumdar

Call Bicara Therapeutics at +1 323...

View the org chart

Register to receive your alert

Report an error